--2025/Q1-- / 1.000K--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q35.000K / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Tesla
TSLA
Microsoft
MSFT
Oracle
ORCL
Alphabet-A
GOOGL
Ecopetrol
EC
US Stock MarketDetailed Quotes
ALT Altimmune
- 6.780
- +0.300+4.63%
Close Feb 19 16:00 ET
- 6.901
- +0.121+1.79%
Post 19:30 ET
482.22MMarket Cap-4.32P/E (TTM)
7.100High6.410Low3.63MVolume6.450Open6.480Pre Close24.92MTurnover5.15%Turnover RatioLossP/E (Static)71.12MShares14.84052wk High3.62P/B477.70MFloat Cap5.27552wk Low--Dividend TTM70.46MShs Float978.000Historical High--Div YieldTTM10.65%Amplitude-1731.000Historical Low6.870Avg Price1Lot Size
Altimmune Key Stats
Altimmune Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Altimmune Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
